RecallDepth
Class I Ongoing

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Company
Fresenius Kabi Usa, Llc
Recall Initiated
November 6, 2025
Posted
December 3, 2025
Recall Number
D-0182-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,199,850 vials
Firm Location
Lake Zurich, IL, United States

Reason for Recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Distribution

Nationwide within the United States as well as AK, HI, and PR.

Lot / Code Info

Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class I Drug recalls